Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TRESIBA safely and effectively. See full prescribing information for TRESIBA. TRESIBA® (insulin degludec) injection, for subcutaneous useInitial U.S. Approval: 2015
Medication labelWhy this: Advisory · dailymed-prescription
TRESIBA is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus. Limitations of Use •Not recommended for the treatment of diabetic ketoacidosis.
- generic_name
- insulin degludec
- product_names
- insulin degludec
- ndc
- 50090-3491, 0169-2550, 50090-3491-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en